Prevention of AIDS

Paul R Jensen

Exploiting Microbial Diversity for Natural Product Discovery

All cancers but non-melanoma skin cancer

Ira Pastan

Development of Improved Mesothelin Targeted Immunotoxins and other Tumor Specific Targeted Immunotoxins Using Proprietary Targeting Moieties

All cancers but non-melanoma skin cancer

Ira Pastan

Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies

All cancers but non-melanoma skin cancer

Hematology and hematologic malignancies Pathology

Erika L Pearce

Tumor-Imposed Glucose Restrictions on T Cells Dampen Immunity

All cancers but non-melanoma skin cancer

Stephane Angers

Wnt proteins signalling pathways (CANADA RESEARCH CHAIRHOLDER)

All cancers but non-melanoma skin cancer

Stuart Le Grice

HIV-1 RNase H as a Therapeutic Target

All cancers but non-melanoma skin cancer

Benjamin Neel

The Gab/Par pathway in development and cancer

All cancers but non-melanoma skin cancer

Chantal Guillemette

Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)

All cancers but non-melanoma skin cancer

John Koren

Novel Combination Therapeutic Strategies to Ablate Resistance to Hsp90 Inhibitors

All cancers but non-melanoma skin cancer